| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 01/09/2017 | 14:49 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:PIP | Pharmathene, (delisted) |
| 01/09/2017 | 14:47 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:PIP | Pharmathene, (delisted) |
| 28/08/2017 | 22:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:PIP | Pharmathene, (delisted) |
| 23/08/2017 | 22:29 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | AMEX:PIP | Pharmathene, (delisted) |
| 22/08/2017 | 22:50 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | AMEX:PIP | Pharmathene, (delisted) |
| 21/08/2017 | 23:02 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | AMEX:PIP | Pharmathene, (delisted) |
| 21/08/2017 | 22:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:PIP | Pharmathene, (delisted) |
| 18/08/2017 | 23:18 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:PIP | Pharmathene, (delisted) |
| 14/08/2017 | 12:08 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:PIP | Pharmathene, (delisted) |
| 10/08/2017 | 15:59 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | AMEX:PIP | Pharmathene, (delisted) |
| 20/07/2017 | 23:02 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | AMEX:PIP | Pharmathene, (delisted) |
| 15/05/2017 | 23:22 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:PIP | Pharmathene, (delisted) |
| 15/05/2017 | 23:17 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | AMEX:PIP | Pharmathene, (delisted) |
| 15/05/2017 | 23:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:PIP | Pharmathene, (delisted) |
| 10/05/2017 | 22:13 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | AMEX:PIP | Pharmathene, (delisted) |
| 05/05/2017 | 19:48 | Edgar (US Regulatory) | (25) | AMEX:PIP | Pharmathene, (delisted) |
| 04/05/2017 | 23:18 | Edgar (US Regulatory) | Securities Registration (section 12(b)) (8-a12b) | AMEX:PIP | Pharmathene, (delisted) |
| 03/05/2017 | 22:57 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | AMEX:PIP | Pharmathene, (delisted) |
| 03/05/2017 | 22:30 | PR Newswire (US) | PharmAthene Reports First Quarter 2017 Financial and Operational Results | AMEX:PIP | Pharmathene, (delisted) |
| 07/04/2017 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | AMEX:PIP | Pharmathene, (delisted) |
| 03/04/2017 | 22:06 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | AMEX:PIP | Pharmathene, (delisted) |
| 31/03/2017 | 20:41 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | AMEX:PIP | Pharmathene, (delisted) |
| 14/03/2017 | 21:45 | Edgar (US Regulatory) | Annual Report (10-k) | AMEX:PIP | Pharmathene, (delisted) |
| 14/03/2017 | 21:03 | PR Newswire (US) | PharmAthene Reports Year-End 2016 Financial and Operational Results | AMEX:PIP | Pharmathene, (delisted) |
| 13/03/2017 | 13:03 | PR Newswire (US) | PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction ... | AMEX:PIP | Pharmathene, (delisted) |
| 08/02/2017 | 14:29 | InvestorsHub NewsWire | PPMH Wholly-Owned Subsidiary, mPath Discovery LLC, Expands Client Base with Multiple New Channel Partnership Agreements | AMEX:PIP | Pharmathene, (delisted) |
| 06/02/2017 | 12:33 | PR Newswire (US) | Altimmune to Present at the BIO CEO & Investor Conference | AMEX:PIP | Pharmathene, (delisted) |
| 03/02/2017 | 23:27 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | AMEX:PIP | Pharmathene, (delisted) |
| 19/01/2017 | 12:30 | PR Newswire (US) | PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases | AMEX:PIP | Pharmathene, (delisted) |
| 22/11/2016 | 23:08 | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | AMEX:PIP | Pharmathene, (delisted) |